Hims & Hers Files Proxy Materials

Ticker: HIMS · Form: DEFA14A · Filed: Apr 25, 2025 · CIK: 1773751

Hims & Hers Health, Inc. DEFA14A Filing Summary
FieldDetail
CompanyHims & Hers Health, Inc. (HIMS)
Form TypeDEFA14A
Filed DateApr 25, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy, regulatory-filing, company-update

Related Tickers: HIMS

TL;DR

HIMS proxy filing is in, no fee needed. Old name Oaktree Acquisition Corp.

AI Summary

Hims & Hers Health, Inc. filed a Definitive Additional Materials (DEFA14A) on April 25, 2025. This filing relates to their proxy statement and indicates no fee was required for this submission. The company was formerly known as Oaktree Acquisition Corp. until April 12, 2019.

Why It Matters

This filing is a routine proxy statement update, providing shareholders with information relevant to upcoming corporate decisions or meetings.

Risk Assessment

Risk Level: low — This is a standard regulatory filing for a public company and does not contain new financial information or strategic changes.

Key Players & Entities

  • Hims & Hers Health, Inc. (company) — Registrant
  • Oaktree Acquisition Corp. (company) — Former company name
  • 20190412 (date) — Date of name change
  • 20250425 (date) — Filing date

FAQ

What type of SEC filing is this?

This is a DEFA14A, specifically filed as Definitive Additional Materials.

Who is the filing company?

The filing company is Hims & Hers Health, Inc.

When was this filing submitted?

The filing was submitted on April 25, 2025.

Was there a fee associated with this filing?

No fee was required for this filing.

What was the company's former name?

The company was formerly known as Oaktree Acquisition Corp.

Filing Details

This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 25, 2025 regarding Hims & Hers Health, Inc. (HIMS).

View full filing on EDGAR

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.